Oregon's New Pharmaceutical Representative Licensure and Disclosure

On June 17, 2022, the state of Oregon released a Pharmaceutical Representative Licensure and Disclosure law requiring pharmaceutical representatives who do business with Healthcare Professionals (HCPs) within Oregon to acquire a license prior to marketing or otherwise promoting products to HCPs licensed in Oregon.

In order to help businesses prepare to meet their obligations under the new Oregon law, the MedPro Systems Compliance Advisory Services team presented a webinar where they discussed:

  • Requirements included in the newly released Oregon Permanent Rule
  • How to properly prepare and file the Oregon disclosure report
  • How to prepare your business for data collection and reporting obligations

Check out the webinar trailer:

Here’s a preview of Elan Schefflein, Senior Compliance Advisor, breaking down the technical requirements of the new Oregon Pharmaceutical Representative Permanent Rule:

Thank you for putting this together. I found the entire session to be easy to understand and loved the practical recommendations on how to deploy within an organization.
Director, Commercial IT
Biopharmaceutical Firm
Thank you so much for the excellent presentation today on the Oregon Pharma Rep Licensure/Reporting requirement – your team did a fantastic job. 
Senior Director, Compliance
Biopharmaceutical Firm

Similar Posts